Ana P. Rodriguez-Gonzalez

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Real-world pegcetacoplan treatment of paroxysmal nocturnal hemoglobinuria patients with an unsatisfactory response to prior therapies.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 11, 2026

Burden and Impact of Infectious Complications After Allogeneic Hematopoietic Cell Transplantation in Older Patients: A GETH-TC Study.

Burden and Impact of Infectious Complications After Allogeneic Hematopoietic Cell Transplantation in Older Patients: A GETH-TC Study.

Journal: Transplantation and cellular therapy

Published: June 03, 2026

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.

Journal: Transplantation and cellular therapy

Published: February 13, 2026

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.

Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC.

Journal: Transplantation and cellular therapy

Published: February 13, 2026

Real-World Validation of the Transplant Conditioning Intensity (TCI) Score in Allogeneic Hematopoietic Cell Transplantation: A Spanish Multicenter Study on behalf of GETH-TC.

Real-World Validation of the Transplant Conditioning Intensity (TCI) Score in Allogeneic Hematopoietic Cell Transplantation: A Spanish Multicenter Study on behalf of GETH-TC.

Journal: Transplantation and cellular therapy

Published: December 27, 2025

C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria.

C3 mutations and poor pegcetacoplan response in paroxysmal nocturnal hemoglobinuria.

Journal: Frontiers in immunology

Published: October 12, 2025

Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC.

Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC.

Journal: Frontiers in immunology

Published: September 06, 2025

Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation.

Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation.

Journal: Cancers

Published: August 20, 2025

Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients.

Variables Associated With the Risk of Severe Mucositis During Autologous Transplantation in Multiple Myeloma Patients.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 23, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Journal: Transplantation

Published: June 17, 2025

The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.

The immune checkpoint LILRB4 promotes immune evasion and is correlated with disease progression and secondary malignancies in chronic lymphocytic leukemia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 27, 2025

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Ultrasensitive detection of circulating multiple myeloma cells by next-generation flow after immunomagnetic enrichment.

Journal: Blood

Published: March 14, 2025

Showing 1-12 of 46

Last Updated: 09/26/2026